These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 23874958)
21. S100A9 has a protective role in inflammation-induced skin carcinogenesis. McNeill E; Hogg N Int J Cancer; 2014 Aug; 135(4):798-808. PubMed ID: 24436096 [TBL] [Abstract][Full Text] [Related]
22. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Hermani A; De Servi B; Medunjanin S; Tessier PA; Mayer D Exp Cell Res; 2006 Jan; 312(2):184-97. PubMed ID: 16297907 [TBL] [Abstract][Full Text] [Related]
23. S100A8/A9 in Inflammation. Wang S; Song R; Wang Z; Jing Z; Wang S; Ma J Front Immunol; 2018; 9():1298. PubMed ID: 29942307 [TBL] [Abstract][Full Text] [Related]
24. Expression and function of S100A8/A9 (calprotectin) in human typhoid fever and the murine Salmonella model. De Jong HK; Achouiti A; Koh GC; Parry CM; Baker S; Faiz MA; van Dissel JT; Vollaard AM; van Leeuwen EM; Roelofs JJ; de Vos AF; Roth J; van der Poll T; Vogl T; Wiersinga WJ PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003663. PubMed ID: 25860480 [TBL] [Abstract][Full Text] [Related]
25. Calprotectin S100A9 calcium-binding loops I and II are essential for keratinocyte resistance to bacterial invasion. Champaiboon C; Sappington KJ; Guenther BD; Ross KF; Herzberg MC J Biol Chem; 2009 Mar; 284(11):7078-90. PubMed ID: 19122197 [TBL] [Abstract][Full Text] [Related]
26. RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition. Yin C; Li H; Zhang B; Liu Y; Lu G; Lu S; Sun L; Qi Y; Li X; Chen W Breast Cancer Res Treat; 2013 Nov; 142(2):297-309. PubMed ID: 24177755 [TBL] [Abstract][Full Text] [Related]
27. miRNA-132-5p mediates a negative feedback regulation of IL-8 secretion through S100A8/A9 downregulation in neutrophil-like HL-60 cells. Zhou Y; Nomigni MT; Gaigneaux A; Tolle F; Wright HL; Bueb JL; Bréchard S Front Immunol; 2023; 14():1274378. PubMed ID: 38292491 [TBL] [Abstract][Full Text] [Related]
28. RAGE-dependent regulation of calcium-binding proteins S100A8 and S100A9 in human THP-1. Eggers K; Sikora K; Lorenz M; Taubert T; Moobed M; Baumann G; Stangl K; Stangl V Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):353-7. PubMed ID: 21472666 [TBL] [Abstract][Full Text] [Related]
29. Novel Pactamycin Analogs Induce p53 Dependent Cell-Cycle Arrest at S-Phase in Human Head and Neck Squamous Cell Carcinoma (HNSCC) Cells. Guha G; Lu W; Li S; Liang X; Kulesz-Martin MF; Mahmud T; Indra AK; Ganguli-Indra G PLoS One; 2015; 10(5):e0125322. PubMed ID: 25938491 [TBL] [Abstract][Full Text] [Related]
30. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding. Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304 [TBL] [Abstract][Full Text] [Related]
31. Substitution of methionine 63 or 83 in S100A9 and cysteine 42 in S100A8 abrogate the antifungal activities of S100A8/A9: potential role for oxidative regulation. Sroussi HY; Köhler GA; Agabian N; Villines D; Palefsky JM FEMS Immunol Med Microbiol; 2009 Jan; 55(1):55-61. PubMed ID: 19087201 [TBL] [Abstract][Full Text] [Related]
32. Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies. Wagner NB; Weide B; Gries M; Reith M; Tarnanidis K; Schuermans V; Kemper C; Kehrel C; Funder A; Lichtenberger R; Sucker A; Herpel E; Holland-Letz T; Schadendorf D; Garbe C; Umansky V; Utikal J; Gebhardt C J Immunother Cancer; 2019 Dec; 7(1):343. PubMed ID: 31806053 [TBL] [Abstract][Full Text] [Related]
33. Citrate-Induced p85α⁻PTEN Complex Formation Causes G Hung KC; Wang SG; Lin ML; Chen SS Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035650 [TBL] [Abstract][Full Text] [Related]
34. S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2. Ghavami S; Kerkhoff C; Chazin WJ; Kadkhoda K; Xiao W; Zuse A; Hashemi M; Eshraghi M; Schulze-Osthoff K; Klonisch T; Los M Biochim Biophys Acta; 2008 Feb; 1783(2):297-311. PubMed ID: 18060880 [TBL] [Abstract][Full Text] [Related]
35. S100A8/A9 induces apoptosis and inhibits metastasis of CasKi human cervical cancer cells. Qin F; Song Y; Li Z; Zhao L; Zhang Y; Geng L Pathol Oncol Res; 2010 Sep; 16(3):353-60. PubMed ID: 19957061 [TBL] [Abstract][Full Text] [Related]
36. miR-17-5p drives G2/M-phase accumulation by directly targeting CCNG2 and is related to recurrence of head and neck squamous cell carcinoma. Huang Q; Shen YJ; Hsueh CY; Guo Y; Zhang YF; Li JY; Zhou L BMC Cancer; 2021 Oct; 21(1):1074. PubMed ID: 34598688 [TBL] [Abstract][Full Text] [Related]
37. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors. Zhang M; Singh R; Peng S; Mazumdar T; Sambandam V; Shen L; Tong P; Li L; Kalu NN; Pickering CR; Frederick M; Myers JN; Wang J; Johnson FM Cancer Lett; 2017 Apr; 392():71-82. PubMed ID: 28126323 [TBL] [Abstract][Full Text] [Related]
38. Observational study on Swedish plaque psoriasis patients receiving narrowband-UVB treatment show decreased S100A8/A9 protein and gene expression levels in lesional psoriasis skin but no effect on S100A8/A9 protein levels in serum. Duvetorp A; Söderman J; Assarsson M; Skarstedt M; Svensson Å; Seifert O PLoS One; 2019; 14(3):e0213344. PubMed ID: 30865695 [TBL] [Abstract][Full Text] [Related]
39. Role of S100A8/A9 for Cytokine Secretion, Revealed in Neutrophils Derived from ER-Hoxb8 Progenitors. Zhou Y; Hann J; Schenten V; Plançon S; Bueb JL; Tolle F; Bréchard S Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445548 [TBL] [Abstract][Full Text] [Related]
40. exMCAM-Fc, an S100A8/A9-mediated-metastasis blocker, efficiently reduced the number of circulating tumor cells that appeared in the blood flow. Tomonobu N; Kinoshita R; Sakaguchi M Mol Biol Rep; 2020 Jun; 47(6):4879-4883. PubMed ID: 32383137 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]